India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
The company also reported significant progress toward its internally defined Sustainable Development Goals
Dr. Reddy's commits to achieving Net Zero greenhouse gas emissions across its value chain by FY 2045
This remarkable increase from 17 in 2021 ranks among the fastest for pharmaceutical companies, establishing Lupin as a leader in sustainable growth
Enzomenib, an oral, small-molecule inhibitor designed to disrupt the menin-MLL protein interaction involved in leukemogenesis
Targeting a 10% reduction in energy and water consumption, and a 30% cut in carbon emissions across facilities by 2025
It offers clear environmental benefits, lower emissions, reduced hazardous material use, and alignment with circular economy goals
Reinforcing commitment to ethical and sustainable growth
Subscribe To Our Newsletter & Stay Updated
